Supplementary table II - Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Supplementary table II: Dupilumab dose optimization and discontinuation.
创建时间：
2023-12-18
